Xudong Yao

4.3k total citations
190 papers, 3.0k citations indexed

About

Xudong Yao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xudong Yao has authored 190 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 71 papers in Pulmonary and Respiratory Medicine and 54 papers in Cancer Research. Recurrent topics in Xudong Yao's work include Bladder and Urothelial Cancer Treatments (42 papers), Prostate Cancer Treatment and Research (26 papers) and Prostate Cancer Diagnosis and Treatment (25 papers). Xudong Yao is often cited by papers focused on Bladder and Urothelial Cancer Treatments (42 papers), Prostate Cancer Treatment and Research (26 papers) and Prostate Cancer Diagnosis and Treatment (25 papers). Xudong Yao collaborates with scholars based in China, United States and Nepal. Xudong Yao's co-authors include Wentao Zhang, Shiyu Mao, Junfeng Zhang, Yadong Guo, Junhua Zheng, Ruiliang Wang, Wenyu Gu, Ziwei Zhang, Yuan Wu and Zongtai Zheng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xudong Yao

174 papers receiving 3.0k citations

Peers

Countries citing papers authored by Xudong Yao

Since Specialization

Citations

This map shows the geographic impact of Xudong Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xudong Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xudong Yao more than expected).

Fields of papers citing papers by Xudong Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xudong Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xudong Yao. The network helps show where Xudong Yao may publish in the future.

Co-authorship network of co-authors of Xudong Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Xudong Yao. A scholar is included among the top collaborators of Xudong Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xudong Yao. Xudong Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative Accuracy of Millimeter-Wave Radar and Polysomnography in Sleep Apnea Detection 2025 ·Medical Science Monitor ·(unknown), Zhiping Zhang, Qiuli Wang, Wen Li, Jiaqi Liu, Changzhan Gu, Peng Xiao, (unknown), Yikai Li, Xudong Yao, (unknown)	0
2	CircCNOT6L modulates alternative splicing of SLC7A11 via splicing factor SRSF2 to confer ferroptosis resistance and promote metastasis in prostate cancer 2025 ·Experimental & Molecular Medicine ·Ji Liu, Niraj Maskey, (unknown), Yadong Guo, Zhijin Zhang, (unknown), (unknown), Hong Wang, Libin Zou, Chuanyong Guo, Bin Yang, Junfeng Zhang, Shiyu Mao, Xudong Yao	2
3	Suicide risk in prostate cancer patients: Trends, predictors, and development of predictive nomograms using SEER data 2025 ·European Journal of Oncology Nursing ·Feng Qi, (unknown), Xudong Yao, (unknown)	0
4	Gender-stratified analysis of sepsis mortality in cancer: a 45-year population-based cohort study 2025 ·JNCI Cancer Spectrum ·Yadong Guo, Ziyou Lin, Wentao Zhang, Haotian Chen, Yongqiang Liu, Ji Liu, Junfeng Zhang, Ai-Hong Zhang, Shiyu Mao, Xudong Yao	0
5	Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population 2025 ·Frontiers in Oncology ·Zhengshi Wang, Haotian Chen, Yongqiang Liu, Libin Zou, Zhijin Zhang, Zhiqiang Yin, Shiyu Mao, Chuanyong Guo, Bin Yang, Pengfei Wu, Xudong Yao	0
6	Electrospun miRNA-21@doxycycline core-sheath nanofibers for a synergistic treatment of diabetic wounds 2024 ·Composites Communications ·Minghui Xu, Xudong Yao, Yichen Wang, (unknown), Wenjia Yang, Pingping Zhang	0
7	Immunosuppressive role of benzo[a]pyrene exposure in prostate cancer progression 2024 ·Journal of Environmental Sciences ·Zhijin Zhang, Wentao Zhang, Huan Wang, Haotian Chen, Hong Wang, Yang Yu, (unknown), (unknown), Yang Wu, (unknown), Yanyan He, Shiyu Mao, Jiang Geng, (unknown), Guangchun Wang, Chuanyong Guo, Daqiang Yin, Xudong Yao	0
8	Olaparib Combined with Abiraterone versus Olaparib Monotherapy for Patients with Metastatic Castration-resistant Prostate Cancer Progressing after Abiraterone and Harboring DNA Damage Repair Deficiency: A Multicenter Real-world Study 2024 ·European Urology Oncology ·Jun Xie, (unknown), Baijun Dong, Wei Chen, (unknown), (unknown), (unknown), (unknown), (unknown), Tingting Zhao, Yang Yu, (unknown), Xudong Yao, Bo Peng, Bin Yang	3
9	The role and mechanism of NAT10‐mediated ac4C modification in tumor development and progression 2024 ·SHILAP Revista de lepidopterología ·(unknown), Libin Zou, (unknown), Yang Yu, Yongqiang Liu, Zhijin Zhang, Ji Liu, Shiyu Mao, Junfeng Zhang, Chuanyong Guo, Wei Li, Jiang Geng, Wentao Zhang, Xudong Yao, Bing Shen	14
10	Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery 2024 ·Advanced Science ·(unknown), Jun Luo, (unknown), Shuai Liu, Yuchen Gao, Hongmin Zhou, (unknown), (unknown), (unknown), Xudong Yao, (unknown), (unknown)	7
11	Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer therapy 2024 ·Biomaterials ·(unknown), Qunqun Bao, Ping Hu, Yuedong Guo, Yan Yang, Xudong Yao, Jianlin Shi	20
12	Urinary exosomes: Potential diagnostic markers and application in bladder cancer 2024 ·Heliyon ·Ji Liu, (unknown), Wentao Zhang, Niraj Maskey, Fuhan Yang, (unknown), (unknown), (unknown), (unknown), Junfeng Zhang, Shiyu Mao, (unknown), Xudong Yao	9
13	The Relationship between Preoperative Urine Culture and Post-Percutaneous Nephrostolithotomy Systemic Inflammatory Response Syndrome: A Single-Center Retrospective Study 2023 ·Journal of Personalized Medicine ·Hongmin Zhou, (unknown), Yuchen Gao, Xudong Yao, Yunfei Xu	4
14	Perioperative change of circulating tumor cells in cytoreductive radical prostatectomy for oligometastatic hormone-sensitive prostate cancer: the preliminary safety evidence from long-term oncologic outcomes 2023 ·International Urology and Nephrology ·Niraj Maskey, Shiyu Mao, (unknown), Yadong Guo, (unknown), (unknown), Jun Xie, Chuanyong Guo, Bin Yang, Xudong Yao	1
15	An ¹⁸F-MD-PSMA (Multi-dentate PMSA Imaging Agent) PET/CT in Prostate Cancer Relapse: Results of a Retrospective Trial 2023 ·Current Radiopharmaceuticals ·Hongliang Fu, Sheng Liang, Miaomiao Xu, (unknown), (unknown), Jian Kang, Linlin Zhang, Zihao Liu, Lin Ding, Yufei Ma, Bin Yang, Xudong Yao, Jun Qi, Hui Wang, (unknown)	0
16	Application of power grid wind monitoring data in transmission line accident warning and handling affected by typhoon 2022 ·Energy Reports ·Yi Zhang, (unknown), Feng Zhang, Xudong Yao, Ang Liu, (unknown), (unknown)	6
17	Identifying the Potential Role and Prognostic Value of the Platelet-Derived Growth Factor Pathway in Kidney Renal Clear Cell Carcinoma 2022 ·Journal of Oncology ·Shiyong Xin, (unknown), Liang Jin, Zhen Zhou, (unknown), (unknown), (unknown), (unknown), (unknown), Xudong Yao, (unknown), (unknown)	1
18	In Silico Establishment and Validation of Novel Lipid Metabolism‐Related Gene Signature in Bladder Cancer 2022 ·Oxidative Medicine and Cellular Longevity ·(unknown), (unknown), (unknown), Shiyong Xin, Liang Jin, (unknown), Zhen Zhou, (unknown), (unknown), (unknown), Xudong Yao, (unknown), Lin Ye	9
19	Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study 2018 ·Cancer Management and Research ·Yadong Guo, (unknown), Shiyu Mao, Junfeng Zhang, Longsheng Wang, Ziwei Zhang, Mengnan Liu, Wentao Zhang, Yuan Wu, Yan Yang, Xudong Yao	24
20	Clinical efficacy and tolerance of sunitinib in the treatment of advanced renal cell carcinoma 2011 ·Zhonghua miniao waike zazhi ·Guohai Shi, Dingwei Ye, Xudong Yao, Shilin Zhang, Bo Dai, Hailiang Zhang, Yijun Shen, Yao Zhu, Yiping Zhu, Chunguang Ma, (unknown), Lifeng Yang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact